Browse by Medical Category
The High Risk Skin Cancer Clinic (HRSCC) at Massachusetts General Hospital is a program designed to provide comprehensive care for those at elevated risk for non-melanoma skin cancer (e.g. squamous cell carcinoma and basal cell carcinoma). The majority of patients are solid organ transplant recipients, those with certain types of leukemia, and patients with genetic syndromes that predispose them to skin cancer.
The HRSCC was established in 2012 and combines the expertise of medical and surgical dermatologists as well as collaboration with Mass General's Transplant Center, Cancer Center, and departments of Otolaryngology (ENT) and Plastic and Reconstructive Surgery.
The focus of the program is early diagnosis of skin cancers, effective treatments, and preventative strategies to minimize the risk of future tumors.
The HRSCC specialty clinic is specifically designed for patients who have/had one of the following conditions:
Please note: If you do not fit the patient eligibility criteria, , please contact our medical dermatology department at 617-726-2914.
During an initial consultation, the patient's skin is examined by one of the clinic's co-directors and suspected skin cancers are addressed. Based on the patient's current skin cancer burden, history of previous skin cancers, and pre-cancers, degree of immune system compromise, and history of sun exposure, an action plan is put into place to address the following:
Dermatologists at the HRSCC work closely with referring services such as the Mass General Transplant Center to tailor a patient's skin cancer action plan to fit their unique medical situation. In the case of solid organ transplant patients, there is often a close collaboration with the transplant team to modify the use of immunosuppressive agents and to utilize oral and/or topical treatments that may be helpful in decreasing the number of new skin cancers.
In rare instances where non-melanoma skin cancer (e.g. squamous cell and basal cell carcinoma) is more advanced and has spread to lymph nodes or to distant organs, the directors of the HRSCC participate in a multi-disciplinary tumor board comprised of representatives from the departments of Otolaryngology (ENT), medical oncology, and radiation oncology who work together to plan the most appropriate interventions to maximize the chance of cure and quality of life.
High Risk Skin Cancer Clinic Massachusetts General HospitalDepartment of Dermatology50 Staniford Street, Suite 270Boston, MA 02114(617) 726-6097
We Welcome Referrals
For referrals from doctors within Partners Healthcare, please refer using EPIC Clinicals, search for MGH High RiskFor referrals from doctors outside of Partners Healthcare, please call or fax us directly.
High Risk Skin Cancer Clinic Massachusetts General HospitalDepartment of Dermatology50 Staniford Street, Suite 270Boston, MA 02114Phone: (617) 726-6097Fax: (617) 726-7417
Chronic lymphocytic leukemia (CLL) is a cancer of the blood in which too many lymphocytes, a type of white blood cell, are produced by the bone marrow and by organs of the lymph system.
Squamous cell skin cancer (sometimes referred to as non-melanoma carcinoma) may appear as nodules, or as red, scaly patches of skin.
High Risk Skin Cancer Clinic
Massachusetts General Hospital
Back to Top